Reading this on a mobile device? Try our optimized mobile version here:

January 28, 2013
Sign upForwardArchiveAdvertise
News for pediatricians and other child health professionals

  Top Stories 
  • Flu activity eases in some regions, CDC says
    Influenza activity appears to be waning in the South, Southeast, Midwest and New England, but levels remain high nationwide, CDC officials said Friday. Hospitalization and deaths overall were up, cases in the Northwest and Southwest are still rising, and eight deaths in the week ending Jan. 19 brought the toll among children to 37. HealthDay News (1/25), CNN (1/26)
Improving chemotherapy dosing
Children's Mercy Hospital and Clinics in Kansas City is an international leader in the field of pediatric clinical pharmacology. Now, this expertise is having a direct impact on the delivery of pediatric cancer care. Read more.
  Pediatric Health Care 
  • Federal report finds decline in childhood exposure to lead
    The average blood level of lead among 1- to 5-year-olds was 92% lower between 2009 and 2010 compared with the recorded level from 1976 to 1980, according to a report by the Environmental Protection Agency. The number of children living in highly polluted counties dropped from 75% in 1999 to 59% in 2009, but the childhood asthma rate increased from 8.7% in 2001 to 9.4% in 2010. News (1/25) LinkedInFacebookTwitterEmail this Story
  • NSAIDs may put children at risk for kidney damage
    U.S. researchers found that in more than 1,000 pediatric cases of kidney damage, 3% were tied to use of nonsteroidal anti-inflammatory drugs. Although most of the patients were teens, four were younger than age 5, according to the study in the Journal of Pediatrics. Researchers noted that dehydration also seemed to be connected to kidney damage. HealthDay News (1/25) LinkedInFacebookTwitterEmail this Story
  • ADHD drug-related ED visits remain unchanged for children, teens
    A Substance Abuse and Mental Health Services Administration report found that the number of emergency department visits related to the use of stimulant drugs for attention deficit/hyperactivity disorder more than doubled between 2005 and 2010, from 13,379 to 31,244. Rates of ED visits among patients younger than 18 were relatively stable, while visits increased for patients ages 18 and older. (1/24), HealthDay News (1/25) LinkedInFacebookTwitterEmail this Story
  • Type 1 diabetes rates rise in Philadelphia children
    The rate of type 1 diabetes in Philadelphia children grew by 29% between 1985 and 2004 and increased by about 70% in those under 5 years old during the same period, according to a study in Diabetes Care. The rate of type 1 diabetes was 18 times higher than that of type 2 diabetes in white children, but only 1.6 times higher in black children, researchers noted. (1/24) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • Few children meet recommended glucose levels
    A study in Diabetes Care revealed 64% of patients under age 6 met the ideal blood glucose levels recommended by the American Diabetes Association. However, researchers found only 43% of those between ages 6 and 13 and 21% of those between ages 13 and 20 met target glucose levels. (1/25) LinkedInFacebookTwitterEmail this Story
  • Safety program curbs infection rates in NICUs
    The rate of central line-associated bloodstream infection in neonatal intensive care units participating in the Agency for Healthcare Research and Quality's safety program dropped by 58% in 11 months. A report said the program helped prevent an estimated 131 infections and up to 41 deaths and saved more than $2 million in medical costs. (1/25) LinkedInFacebookTwitterEmail this Story
  Hot Topics 

Top five news stories selected by AAP SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Health Policy & Regulations 
  • FDA expands approval for childhood leukemia drug
    The FDA approved Friday the expanded use of Novartis' leukemia drug Gleevec to include children newly diagnosed with Philadelphia chromosome positive acute lymphoblastic leukemia. The drug should be combined with chemotherapy and carries a risk of several adverse reactions, including liver toxicity and infections, the agency said. Bloomberg Businessweek (1/25) LinkedInFacebookTwitterEmail this Story
  The Last Word - News from the AAP 
  • Revised AAP refusal to vaccinate form
    The AAP form, "Documenting Parental Refusal to Have Their Children Vaccinated," was developed by the Section on Infectious Diseases Executive Committee as a resource for pediatricians when talking with parents who are hesitant or refuse to have their children fully vaccinated. The newly revised form, as well as other practice resources that address common reasons for parental hesitancy or refusal to vaccinate, can be accessed on the AAP Immunization and the SOID websites. LinkedInFacebookTwitterEmail this Story
  • Save the date!
    Don't forget to save the date for the AAP 2013 National Conference and Exhibition, Oct. 26 to 29, as we celebrate magical moments in Orlando, Fla. To receive important conference information, visit the NCE website or “Like us” on Facebook. LinkedInFacebookTwitterEmail this Story
Learn more about AAP ->AAP Member Center  |  Advocacy  |  Bookstore & Publications  |  Continuing Education

If fate means you to lose, give him a good fight anyhow."
--William McFee,
British-American writer

LinkedInFacebookTwitterEmail this Story

This news roundup is provided as a timely update to AAP members and other health professionals about child health topics in the media. Links to articles are provided for the convenience of pediatricians who may find them of use in discussions with patients or colleagues.
External Resources are not a part of the website. AAP is not responsible for the content of sites that are external to the AAP. Linking to a website does not constitute an endorsement by AAP of the sponsors of the site or the information presented on the site.
Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director: Aaron Kern 202-407-7866
A powerful website for SmartBrief readers including:
 Recent AAP SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information